| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 11/04/2004 | WO2003077847A3 Substituted amides |
| 11/04/2004 | US20040220404 For therapy of obesity, diabetes, depression, or anxiety in a mammal |
| 11/04/2004 | US20040220403 For therapy and prophylaxis of Tachykinin-mediated diseases |
| 11/04/2004 | US20040220178 Substituted heterocycle fused gamma-carbolines |
| 11/04/2004 | US20040220177 Anticancer agents |
| 11/04/2004 | US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide |
| 11/04/2004 | CA2523291A1 Tricyclic indole derivatives and their use in the treatment of alzheimer`s disease |
| 11/03/2004 | EP1472219A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 11/03/2004 | EP0877748B1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 11/03/2004 | CN1542011A Sulphur containing heterocyclic and naphthalimides compound and use thereof |
| 11/02/2004 | CA2103454C Macrocyclic immunomodulators |
| 10/28/2004 | WO2004092134A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 10/28/2004 | WO2004092131A1 Indole derivatives as ppar modulators |
| 10/28/2004 | WO2004091504A2 Substituted quinobenzoxazine analogs |
| 10/28/2004 | US20040214833 such as 3-methyl-9-methylamino-7-(pyridin-4-yl)-3H-imidazo[4,5-f]quinoline for use as analgesics |
| 10/28/2004 | US20040214814 Pyrazole compounds useful as protein kinase inhibitors |
| 10/28/2004 | DE10316659A1 Tricyclische Heteroaromatische Verbindungen Tricyclic heteroaromatic compounds |
| 10/28/2004 | CA2521810A1 Substituted quinobenzoxazine analogs |
| 10/28/2004 | CA2521364A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 10/27/2004 | EP1471068A1 Process for total synthesis of ecteinascidins and intermediates therefor |
| 10/27/2004 | EP1471067A1 Derivatives of 2-oxothiadiazoline-4-carboxylic acid and its use as active photoprotective agent |
| 10/27/2004 | EP1470131A2 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| 10/27/2004 | EP1470125A1 Aminopiperidine derivatives |
| 10/27/2004 | EP1469849A1 Treating stress response with chemokine receptor ccr5 modulators |
| 10/27/2004 | CN1541097A 2-amino-4, 5-trisubstituted thiazolyl derivatives |
| 10/26/2004 | US6809203 Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analogs thereof |
| 10/26/2004 | US6809202 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 10/26/2004 | CA2127411C Tricyclic derivatives |
| 10/21/2004 | WO2004089950A1 Tricyclic heteroaromatic compounds |
| 10/21/2004 | WO2004089356A2 Targeted bone marrow protection agents |
| 10/21/2004 | WO2004058144A3 Antibacterial agents |
| 10/21/2004 | WO2004056879A3 Spirotetrathiocarbamates and spirooxothiocarbamates |
| 10/21/2004 | WO2004056786A3 Pyrimidine derivates for the treatment of abnormal cell growth |
| 10/21/2004 | US20040209897 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds |
| 10/21/2004 | US20040209896 For crops, animals |
| 10/21/2004 | US20040209895 inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases |
| 10/21/2004 | US20040209867 for treatment of disorders (sleeping, feeding) relating to or affected by the 5-HT6 receptor; serotonin receptor antagonists |
| 10/21/2004 | US20040209864 Substituted heterocycle fused gamma-carbolines |
| 10/20/2004 | EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF: MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION |
| 10/20/2004 | EP1467978A1 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 10/20/2004 | EP1109551A4 4-amino-3-mercapto-1,2,4-triazoles |
| 10/20/2004 | CN1171892C Thienothiazine compound with anti-inflammatory and antalgic activity and its preparing process and usage |
| 10/20/2004 | CN1171872C Compounds for modulation of PPAP gamma activity |
| 10/20/2004 | CN1171589C Urease inhibitors |
| 10/19/2004 | US6806273 Compounds |
| 10/19/2004 | CA2343336C Processes for preparing intermediates to nizatidine |
| 10/14/2004 | WO2004087145A2 Antibacterial agents |
| 10/14/2004 | US20040204477 For use as antiproliferative agents |
| 10/14/2004 | US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders |
| 10/13/2004 | EP1466625A1 Preventives/remedies for urinary disturbance |
| 10/13/2004 | EP1466527A1 Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method of controlling weed with the same |
| 10/13/2004 | EP1465888A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 10/13/2004 | EP1465882A2 Hetrocyclic modulators of nuclear receptors |
| 10/13/2004 | CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative |
| 10/13/2004 | CN1170832C Substituted thiazol [3,2-alphal]azatropylidene derivatives |
| 10/07/2004 | WO2004043911A3 N-cycloalkylglycines as hiv protease inhibitors |
| 10/07/2004 | WO2003049679A3 Mitotic kinesin inhibitors |
| 10/07/2004 | US20040198974 applying deemed racemates to continuos enantioselective liquid chromatography like SMB (simulated moving bed); for industrial scale production of pure enantiomers of amino acids useful as intermediates in organic synthesis such as N-benzyloxycarbonyl-tert-leucine |
| 10/07/2004 | US20040198783 Targeted bone marrow protection agents |
| 10/07/2004 | US20040198768 Method for inhibiting 5-lipoxygenase using a benzoxazole derivative or an analogue thereof |
| 10/07/2004 | US20040198756 Piperidien compound; bactericide |
| 10/07/2004 | US20040198741 Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
| 10/06/2004 | EP1463735A1 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 10/06/2004 | EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 10/06/2004 | EP1463715A1 Novel glucagon antagonists |
| 10/06/2004 | EP1463502A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 10/06/2004 | CN1535272A Nitrogen-containing bicyclic heterocycles |
| 10/06/2004 | CN1169811C Method for synthesizing (3aS)-5,5-dioxo-2,3,3a,4-tetrahydric-1H-pyrrolo [2,1-c][1,2,4] benzodiazine |
| 10/05/2004 | US6800759 Racemization and enantiomer separation of clopidogrel |
| 10/05/2004 | US6800653 Anticancer agents |
| 10/05/2004 | US6800623 A 1,3-dithia-4-aza-acenaphthylene 3,3-dioxide compounds; treating psychological disorders |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 09/30/2004 | WO2004083218A1 Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists |
| 09/30/2004 | WO2004082606A2 Fused pyrrole compounds |
| 09/30/2004 | WO2004082602A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | WO2003072535A8 Substituted hydroxyethylamines |
| 09/30/2004 | US20040192710 Such as trans-4-amino-3,4-dihydro-2,2-dimethyl-6-cyano-2H-benzopyran; for use as antiarrhythmic agents |
| 09/30/2004 | US20040191210 Compounds |
| 09/30/2004 | CA2518830A1 Carboxamide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | CA2518679A1 Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists |
| 09/30/2004 | CA2517034A1 Fused pyrrole compounds |
| 09/29/2004 | EP1461339A2 Spiroazacyclic compounds as monoamine receptor modulators |
| 09/29/2004 | EP1461318A2 Tetrahydroquinoline analogues as muscarinic agonists |
| 09/29/2004 | EP1461035A2 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
| 09/29/2004 | EP1189905B1 Substituted heterocycle fused gamma-carbolines |
| 09/29/2004 | CN1533391A Tricyclic compounds and their uses |
| 09/28/2004 | US6797709 Sexual disorders |
| 09/23/2004 | WO2004080962A1 2,4,6-phenyl substituted cyclic ketoenols |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004005472A3 Inhibitors of ftsz and uses thereof |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186094 Substituted pyridoindoles as serotonin agonists and antagonists |
| 09/23/2004 | US20040186091 Triazole compounds useful in therapy |
| 09/23/2004 | DE10311300A1 New 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols, useful as total or selective herbicides and pesticides, e.g. insecticides, acaricides and nematocides for plant protection |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1274709B1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 09/22/2004 | EP1265904B1 Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | EP1192165B1 Substituted heterocycle fused gamma-carbolines |